Marilyn Hepperle
Internal Medicine · Prattville, ALNPI 1215086111
Payments from drug & device makers
Across 254 payments — averaging $16.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$693
- Amgen$475
- Lilly USA, LLC$428
- GSK$393
- AstraZeneca$350
- Pfizer$278
- plus $1K from 28 others
What the payments were for
- Food & beverage$4,089100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 54 | $693 |
| Amgen | 28 | $475 |
| Lilly USA, LLC | 30 | $428 |
| GSK | 22 | $393 |
| AstraZeneca | 22 | $350 |
| Pfizer | 15 | $278 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $201 |
| Teva Pharmaceuticals USA, Inc. | 10 | $186 |
| Novo Nordisk | 10 | $170 |
| Novartis | 6 | $82 |
| Boehringer Ingelheim | 4 | $81 |
| Eisai Inc. | 4 | $64 |
| Mylan Specialty L.p. | 3 | $59 |
| Dexcom, Inc. | 3 | $59 |
| Idorsia Pharmaceuticals US Inc | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Exact Sciences | 3 | $51 |
| Intuitive Surgical | 1 | $45 |
| Forte Bio-pharma LLC | 2 | $40 |
| Scilex Pharmaceuticals Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $33 |
| Merck | 2 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Assertio Therapeutics, Inc. | 1 | $17 |
| Bayer | 1 | $17 |
| Tolmar, Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Inogen, Inc. | 1 | $12 |
How this compares
$4,098 in reported general payments places this provider in the 80th percentile of 1,533 internal medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nucynta ErTapentadol Hcl | 30 | $41,483 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,248 | $39,379 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 41 | $32,657 |
| LinzessLinaclotide | 26 | $32,117 |
| EliquisApixaban | 25 | $27,747 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 867 | $26,449 |
| BelbucaBuprenorphine Hcl | 22 | $22,363 |
| OxycontinOxycodone Hcl | 12 | $19,594 |
| MounjaroTirzepatide | 13 | $13,893 |
| MyrbetriqMirabegron | 19 | $11,727 |
| Gabapentin | 660 | $9,760 |
| Fentanyl | 42 | $4,943 |
| DayvigoLemborexant | 11 | $4,276 |
| Oxycodone Hcl | 206 | $3,682 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 31 | $3,191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $393 | $32,65741 claims |
| AbbVieLinzess | $693 | $32,11726 claims |
| PfizerEliquis | $278 | $27,74725 claims |
| Lilly USA, LLCMounjaro | $428 | $13,89313 claims |
| Astellas Pharma US IncMyrbetriq | $33 | $11,72719 claims |
| Eisai Inc.Dayvigo | $64 | $4,27611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,533 internal medicine providers in Alabama.
Other internal medicine in Prattville
- Harry StuddardMobile$12.9M
- Almena FreeAnniston$12.7M
- Hayes WilliamsVestavia$10.4M
- David DeatkineBirmingham$8M
- James SullivanBirmingham$6M
- Ramy TomaBirmingham$5.1M
- Barry McLeanHomewood$4M
- William KirbyBirmingham$2.3M
- Saadat AnsariHuntsville$2.1M
- Gregory FlippoTrussville$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.